Video

Liver Cancer: What's On the Horizon?


Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Image of man.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Image of a woman wearing a headband and glasses